Yes, semaglutide can cause headaches in some patients
In addition to helping with insulin resistance, these medications can benefit those with PCOS in other ways: by promoting weight loss, regulating menstrual cycles, reducing chronic inflammation, and lowering the risk of cardiovascular disease and non-alcoholic fatty liver disease, conditions that can be associated with PCOS
For people with insulin resistance, diabetes, or who are struggling with their weight, increasing GLP-1 levels naturally can help curb symptoms and assist with weight loss or management
doi: 10.1016/S0140-6736(87)91194-9 22 HolstJJ
Following the results of the SELECT trial, the FDA approved a new indication for Wegovy (semaglutide) in March 2024: to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight
Escalating Obesity Epidemic and Weight-Loss Approvals World Health Organization data confirm that worldwide obesity prevalence nearly tripled between 1975 and 2024, affecting more than 890 million adults